What are the recent trends in market size and growth for the cardiac marker testing market?
The cardiac marker testing market size has grown rapidly in recent years. It will grow from $6.52 $ billion in 2024 to $7.19 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in geriatric population, rise in educational campaigns, increasing awareness, rising healthcare infrastructure, and rising patient population.
The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $10.56 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising incidences of cardiovascular diseases, increasing strategic collaborations and partnerships, increasing research and development initiatives, favorable reimbursement policies and rising demand for point-of-care (POC) testing. Major trends in the forecast period include advanced diagnostic technologies, automated analyzers, advanced cardiac marker testing assays, digital health technologies, and emergence of integrative technologies.
Get Your Free Sample of The Global Cardiac Marker Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp
How have varous drivers impacted the growth of the cardiac marker testing market?
The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac marker testing market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The rising cases of cardiovascular diseases are caused due to an unhealthy diet, physical inactivity, tobacco use, harmful use of alcohol, and air pollution. Cardiac marker testing is required for cardiovascular diseases to accurately diagnose, assess the severity, and monitor the progression or response to treatment of heart conditions by detecting specific biomarkers released during myocardial injury. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, up 4.0% from 224.4 per 100,000 when compared to 2023. Sudden cardiac arrest was responsible for 20,114 deaths in the U.S. in 2021. Therefore, the rising incidence of cardiovascular diseases drives the cardiac marker testing market.
What are the primary segments of the cardiac marker testing market?
The cardiac marker testingmarket covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments
2) By Biomarker Type: Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Cardiac Biomarkers
3) By Application: Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Reagents and Kits: Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
2) By Instruments: Point-of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report
Which firms are leading the cardiac marker testing market?
Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Guangzhou Wondfo Biotech Co. Ltd., Randox laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Kainos Medicine Inc., Alere Inc., Nano-Ditech Corporation, 1Drop Diagnostics
How will industry trends affect the trajectory of the cardiac marker testing market?
Major companies operating in the cardiac marker testing market are focused on developing technologically advanced products, such as cardiac assays, to provide valuable, precise information about heart health and function. Cardiac assays are diagnostic tests designed to measure biomarkers or other indicators in the blood or other samples to assess heart function, diagnose cardiovascular diseases, or evaluate the risk of heart-related conditions. For instance, in October 2023, Mindray, a China-based medical device company, launched the troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTnI assay distinguishes itself with exceptional sensitivity, precision, and reliability, surpassing minimum requirements by achieving a 93% detection rate between the limit of detection (LoD) and the 99th percentile upper reference limit (URL) and maintaining an imprecision coefficient of variation (CV) below 5% at the 99th URL, making it highly effective in detecting myocardial injury. Mindray’s NT-proBNP assay is an important cardiac marker for heart failure, showing high precision with a coefficient of variation (CV) of =5%. It also effectively minimizes interference from 55 common heart disease medications, ensuring accurate detection and management of heart failure.
Which geographic trends are shaping the cardiac marker testing market, and which region has the highest market share?
North America was the largest region in the cardiac marker testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cardiac Marker Testing Market Report 2025 Offer?
The cardiac marker testing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cardiac marker testing refers to a series of diagnostic tests used to measure specific substances in the blood that can indicate damage or stress to the heart. These markers are often proteins or enzymes released into the bloodstream when the heart muscle is injured. Cardiac marker tests are crucial for diagnosing and evaluating conditions such as myocardial infarction (heart attack), heart failure, and other cardiac diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19358
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
